Intravenous Liposomal Amphotericin B Efficacy and Safety for Cutaneous and Mucosal Leishmaniasis: A Systematic Review and Meta-analysis

BACKGROUND: Tegumentary leishmaniasis is often subject to limited funding, underpowered studies, and a paucity of high-quality interventional studies. Intravenous liposomal amphotericin B (L-AmB) has been increasingly used to treat cutaneous and mucosal leishmaniasis (CL and ML, respectively) despit...

Descripción completa

Detalles Bibliográficos
Autores principales: Chivinski, Jeffrey, Nathan, Keren, Naeem, Faheel, Ekmekjian, Taline, Libman, Michael D, Barkati, Sapha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372713/
https://www.ncbi.nlm.nih.gov/pubmed/37520422
http://dx.doi.org/10.1093/ofid/ofad348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372713/
https://www.ncbi.nlm.nih.gov/pubmed/37520422
http://dx.doi.org/10.1093/ofid/ofad348

Ejemplares similares